Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients
Status:
Completed
Trial end date:
2018-02-08
Target enrollment:
Participant gender:
Summary
A randomized multiple-dose, placebo-controlled, parallel group design consisting of a 2-week
run-in period followed by a 6-week treatment period of the placebo, Test product (Budesonide
80 mcg / Formoterol fumarate dihydrate 4.5 mcg), or Reference product Symbicort® inhalation
aerosol.
Phase:
Phase 3
Details
Lead Sponsor:
3M
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate